Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Basis of preparation (Tables)

v3.25.1
Basis of preparation (Tables)
12 Months Ended
Dec. 31, 2024
Basis of preparation.  
Schedule of company's subsidiary

Name

    

Place of Incorporation

    

Ownership

 

XORTX Pharma Corp.

 

Canada

 

100%